Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014


Pharmaceutical Microbiology

21 Jan 2014 - 22 Jan 2014 - London, UK



Bookmark and Share


SMi’s reputable Pharamceutical Microbiology conference returns for its 3rd installment on 20th and 21st January, 2014, London UK.

Pharmaceutical Microbiology 2014 will draw upon the experiences and knowledge from experts and specialists around the globe to provide first-class presentations and stimulating discussions.

The conference will aim to focus on the regulatory aspect, with topics addressing preparations for auditing, what to expect during the inspection process, and how to rectify poor situations. There will also be considerable spotlight on novel rapid methods, case studies from the USA, their implementation, and the current regulatory view on methods. Among these hot topics the event will also examine sterility assessment, risk management, and contamination control.

KEY BENEFITS OF ATTENDING:

Regulatory body representation and update – what to expect from inspection, how to prepare your lab, and how to rectify situations when things go wrong.

Discover cutting edge rapid methods, how to implement the technology, and the regulatory stance

Hear specialist advice on contamination control and risk management to minimise costs and maximise efficiency

Learn about hot topics which include objectionable organisms, viral contaminations, update on the pharmacopeias, and quality by design.

Discuss case studies and experiences with expert speakers and delegates from across the UK, USA, and Europe.

KEY SPEAKERS:

Phil Duncanson, Site Microbiologist & QC Lead, MedImmune

Mary-Anne Weatherhead, Qualified Person, Pfizer

Andrew Bartko, Senior Scientist, Battelle

William Wade, Professor of Oral Microbiology, Barts and The London

Brendan Gilmore, Senior Lecturer in Pharmaceutical Microbiology, Queen’s University Belfast

Amy McDaniel, Associate Director, Production Operations, Pfizer

Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca

Pierre Raboisson, Head of Medicinal Chemistry, Johnson & Johnson

Olivier Chancel, Head of Pharmaceutical Support, Merial Sas (Sanofi)

Di Morris, Consultant, Pharmaceutical Solutions Ltd. (ex-MHRA)

Stephen Rawling, Microbiology Team Leader, GSK

John Duguid, Principal Process Analytical Scientist, Genzyme

Kim Bowers, Senior Supervisor, Pfizer

Hilary Chan, Quality Scientist IV, Pfizer

Erika Pfeiler, Microbiologist, FDA

Steven Donald, Microbiologist, FDA

The previous 2 events in the Microbiology series received positive feedback from the industry including Thermo Fischer Scientific – “The delegate quality was good” , Pfizer – “Topics were interesting and relevant” and Groninger & co gmbh- Very diverse multi facetted event

Be sure to take part in the next instalment by registering online at:

http://www.smi-online.co.uk/goto/2014pharma-microbiology29.asp

Alternatively contact John Collins on +44(0)20 7827 6734 or email jcollins@smi-online.co.uk


Further information
Scientific News
Flowering Regulation Mechanism Discovered
Monash researchers have discovered a new mechanism that enables plants to regulate their flowering in response to raised temperatures.
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Nanoparticles Present Sustainable Way to Grow Food Crops
Nanoparticle technology can help reduce the need for fertilizer, creating a more sustainable way to grow crops such as mung beans.
How Scientists Use DNA to Track Disease Outbreaks
They’re the top questions on everyone’s mind when a new disease outbreak happens: where did the virus come from? When did this happen? How long has it been spreading in a particular country or group of people?
Genetic Risk Factors of Disparate Diseases Share Similar Biological Underpinnings
Penn Institute for Biomedical Informatics and colleagues identify "roadmap" of disease mechanisms to identify candidate drug targets.
Drugs that May Combat Deadly Antibiotic-Resistant Bacteria Uncovered
Study identifies 79 compounds that inhibit carbapenem-resistant Enterobacteriaceae (CRE).
Stem Cells Know How to Unwind
Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long-term and unrestricted developmental potential in embryonic stem cells.
HIV Particles Used to Trap Intact Mammalian Protein Complexes
Belgian scientists from VIB and UGent developed Virotrap, a viral particle sorting approach for purifying protein complexes under native conditions.
Childhood Asthma Research Receives $2M
Research into the impact of a child’s upbringing and social and physical environments on the development of asthma will receive $2 million to tackle the condition that affects as many as one in three Canadians.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!